PharmaBoardroom

Philippe de Pougnadoresse – Country President &…

Philippe de Pougnadoresse, country president & general manager pharma for Novartis Belgium & Luxembourg, outlines his affiliate’s fast and…

The Wellcome Trust’s Jeremy Farrar Speaks Out Against…

Jeremy Farrar, director of the Wellcome Trust, spoke to Financial Times correspondent Vanessa Kortekaas on 25 June 2020 about the global race to…

Vincent Stephenne – Managing Director, BePharBel…

Vincent Stephenne, managing director of Belgian CDMO BePharBel Manufacturing, highlights the company’s innovative approach to developing new galenic…

Christophe Van Damme – Vice President & General…

Christophe Van Damme, vice president and general manager of Perrigo Belgium and Luxembourg, shines a light on the transformation for Perrigo since its…

Sanofi Makes USD 679 Million Investment in French Vaccine…

French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679 million in vaccine manufacturing…

Accumulating Barriers to Care: Double Jeopardy for US Patients

Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for…

Pharma Faces: Veronique Walsh, BMS Benelux

Veronique Walsh, general manager of Bristol Myers Squibb for Belgium, the Netherlands, and Luxembourg (Benelux), recently spoke to PharmaBoardroom…

Merck KGaA: Big-Ticket Investments in Manufacturing Scale &…

Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number of headline-grabbing investments…

Yeul-Hong Kim – Director, K-MASTER, South Korea

Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data for Korean oncology professionals.…

EMA: Ireland’s Emer Cooke Set to Take the Helm

The European Medicines Agency (EMA), Europe’s regulatory body for medicines, has nominated Irish candidate Emer Cooke to as its new executive…

Emmanuel Hanon – Senior VP, Vaccines R&D, GSK

In an exclusive interview, GSK’s Senior VP for Vaccines R&D Dr Emmanuel Hanon discusses how the sharing of GSK’s adjuvant technology with a…

Brett Monia – CEO, Ionis Pharmaceuticals

Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development…

Tagged with